Hexcel's Q2 revenues outpace forecasts, but shrinking margins and lower commercial aerospace sales volume weigh on results.

The European Commission (EC) has granted approval to Sanofi's Sarclisa in combination with a regimen of bortezomib, lenalidomide and dexamethasone (VRd) to treat multiple myeloma in adults. Sarclisa ...

Discover the top Dividend Challengers with consistent payouts for 5-9 years! Explore 2025's highest-quality picks & scoring ...